MedPath

South Rampart Pharma, LLC

South Rampart Pharma, LLC logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Pharmacokinetics of SAD/MAD Oral Doses of SRP-3D (DA)

Phase 1
Not yet recruiting
Conditions
Pain
Interventions
First Posted Date
2022-08-02
Last Posted Date
2024-12-10
Lead Sponsor
South Rampart Pharma, LLC
Target Recruit Count
56
Registration Number
NCT05484414
Locations
🇺🇸

Quotient Sciences-Miami, Inc., Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath